Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10918633 | Radiotherapy and Oncology | 2014 | 6 Pages |
Abstract
Our study has shown that bowel symptoms following prostate IMRT/IGRT are due to numerous diagnoses other than PRD, including malignancy. Routine referral pathways should be developed for endoscopic evaluation/specialist review for patients with new or persistent bowel symptoms (or positive FOBT) following prostate radiotherapy. This recommendation should be considered for incorporation into national guidelines.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Myo Min, Benjamin Chua, Yvonne Guttner, Ned Abraham, Noel J. Aherne, Matthew Hoffmann, Michael J. McKay, Thomas P. Shakespeare,